We are live on
!
Find out more
HA
HC Advisors Portfolio holdings
AUM
$165M
1-Year Est. Return
20.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.66%
1 Year Est. Return
+20.85%
3 Year Est. Return
+63.52%
5 Year Est. Return
+65.27%
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$2.21M
(+1.6%)
Cap. Flow
-$869K
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
66.47%
Holding
62
New
1
Increased
19
Reduced
22
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$782K |
| 2 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$680K |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$241K |
| 4 |
BCTK
Baron Technology ETF
BCTK
|
+$227K |
| 5 |
Grindr
GRND
|
+$199K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sprott Physical Silver Trust
PSLV
|
+$890K |
| 2 |
Sprott Gold Miners ETF
SGDM
|
+$459K |
| 3 |
CRISPR Therapeutics
CRSP
|
+$254K |
| 4 |
Vanguard Consumer Staples ETF
VDC
|
+$253K |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$206K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 88.54% |
| 2 | Technology | 5.01% |
| 3 | Industrials | 1.89% |
| 4 | Financials | 1.65% |
| 5 | Energy | 0.84% |
Similar funds
ASC
CRIG
LFA
VEM
TTIC
GPWA
HPBT
HCM
HC Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, HC Advisors held 62 positions worth $145M, up 1.6% from $142M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.8%. HC Advisors opened 1 new position and exited 2, leaving the 62-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 88% a quarter earlier, followed by Technology and Industrials.
- HC Advisors's largest Q4 2025 buy was Baron Technology ETF: 9,023 shares worth $227K.
- HC Advisors added most to Schwab US Large-Cap Growth ETF in Q4 2025, an estimated $782K increase.
- HC Advisors's biggest Q4 2025 reduction was Sprott Physical Silver Trust, cutting an estimated $890K.
- HC Advisors fully exited CRISPR Therapeutics in Q4 2025, selling an estimated $254K.
- HC Advisors's ten largest holdings make up 66% of its $145M portfolio in Q4 2025.
- HC Advisors opened 1 new position and closed 2 in Q4 2025.
- HC Advisors's portfolio value rose 1.6% quarter-over-quarter to $145M.
Based on HC Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.